Bioptic Laboratory Ltd Pilsen Czech Republic

Department of Pathology Charles University Faculty of Medicine in Pilsen Pilsen Czech Republic

Department of Pathology University of Helsinki and Helsinki University Hospital HUS Diagnostiikkakeskus HUSLAB Patologia PL 720 00029 HUS Topeliuksenkatu 32 Helsinki Finland

Institute of Biomedicine Pathology University of Turku and Turku University Hospital Turku Finland

Zobrazit více v PubMed

WHO Classification of Tumours Editorial Board. Head and neck tumours (2022). Lyon (France): International Agency for Research on Cancer; (WHO classification of tumours series, 5th ed.; vol. 9). https://tumourclassification.iarc.who.int/chapters/52 . Accessed 31 Jul 2024

Skálová A, Hyrcza MD, Leivo I (2022) Update from the 5th edition of the World Health Organization classification of head and neck tumors: salivary glands. Head Neck Pathol 16:40–53. https://doi.org/10.1007/s12105-022-01420-1 PubMed DOI PMC

Bishop JA, Rooper LM, Sangoi AR, Gagan J, Thompson LDR, Inagaki H (2021) The myoepithelial cells of salivary intercalated duct-type intraductal carcinoma are neoplastic: a study using combined whole-slide imaging, immunofluorescence, and RET fluorescence in situ hybridization. Am J Surg Pathol 45:507–515. https://doi.org/10.1097/PAS.0000000000001605 PubMed DOI

Skálová A, Ptáková N, Santana T, Agaimy A, Ihrler S, Uro-Coste E et al (2019) NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary intraductal carcinoma, including invasive and metastatic tumors: is “intraductal” correct? Am J Surg Pathol 43:1303–1313. https://doi.org/10.1097/PAS.0000000000001301 PubMed DOI

Skálová A, Vanecek T, Uro-Coste E, Bishop JA, Weinreb I, Thompson LDR et al (2018) Molecular profiling of salivary gland intraductal carcinoma revealed a subset of tumors harboring NCOA4-RET and novel TRIM27-RET fusions: a report of 17 cases. Am J Surg Pathol 42:1445–1455. https://doi.org/10.1097/PAS.0000000000001133 PubMed DOI

Nakaguro M, Urano M, Suzuki H, Yamada K, Sakaguchi A, Ogura K et al (2018) Low-grade intraductal carcinoma of the salivary gland with prominent oncocytic change: a newly described variant. Histopathology 73:314–320. https://doi.org/10.1111/his.13517 PubMed DOI

Bishop JA, Nakaguro M, Whaley RD, Ogura K, Imai H, Laklouk I et al (2021) Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations. Histopathology 79:338–346. https://doi.org/10.1111/his.14296 PubMed DOI PMC

Ross JS, Wang K, Chmielecki J, Gay L, Johnson A, Chudnovsky J et al (2016) The distribution of BRAF gene fusions in solid tumors and response to targeted therapy. Int J Cancer 15(138):881–890. https://doi.org/10.1002/ijc.29825 DOI

Holderfield M, Deuker MM, McCormick F, McMahon M (2014) Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond. Nat Rev Cancer 14:455–467. https://doi.org/10.1038/nrc3760 PubMed DOI PMC

Sisdelli L, Cordioli MICV, Vaisman F, Moraes L, Colozza-Gama GA, Alves PAG Jr et al (2019) AGK-BRAF is associated with distant metastasis and younger age in pediatric papillary thyroid carcinoma. Pediatr Blood Cancer 66:e27707. https://doi.org/10.1002/pbc.27707 PubMed DOI

Moran JMT, Le LP, Nardi V, Golas J, Farahani AA, Signorelli S, Onozato ML et al (2022) Identification of fusions with potential clinical significance in melanoma. Mod Pathol 35:1837–1847. https://doi.org/10.1038/s41379-022-01138-z PubMed DOI

Vojnic M, Kubota D, Kurzatkowski C, Offin M, Suzawa K, Benayed R et al (2019) Acquired BRAF rearrangements induce secondary resistance to EGFR therapy in EGFR-mutated lung cancers. J Thorac Oncol 14:802–815. https://doi.org/10.1016/j.jtho.2018.12.038 PubMed DOI PMC

Domen A, Paesschen CV, Zwaenepoel K, Lambin S, Pauwels P, Rasschaert M et al (2022) Excellent response to MEK inhibition in an AGK-BRAF gene fusion driven carcinoma: case report and literature review. Anticancer Res 42:373–379. https://doi.org/10.21873/anticanres PubMed DOI